Teratogens

Slide 1 of 10: Synopsis

Human Development Video Activity
true
true
You must read each slide, and complete any questions on the slide, in sequence.
embryonic period
The prenatal stage of development from approximately 3 weeks to 8 weeks after conception during which the embryonic cells first resemble a human being. By the end of the embryonic period, most basic organs have developed.
germinal period
The earliest stage of prenatal development that begins with conception and lasts until implantation in the uterus at anywhere from 6 to 12 days after fertilization. Often the germinal period is used to refer to the first 2 weeks after fertilization.
genotype
The complete set of genes for an organism. The complete genetic inheritance for an organism.
implantation
The process of the blastocyst attaching to the uterine lining. Implantation occurs anywhere from 6 to 12 days after fertilization. Upon successful implantation, the mother’s hormones trigger her menstrual cycle to stop.
spontaneous abortion
Also known as a miscarriage. A pregnancy that ends on its own before the 20th week.
teratogen
An agent or condition that has the ability to interfere with healthy prenatal development and may lead to birth defects or even death.
A close-up of the head of a fetus in the womb

Author

Catherine F. Robertson, Grossmont College
S. Stavros Valenti, Hofstra University

Synopsis

Teratogens are substances and conditions that can impair prenatal development and lead to birth defects or even death. Teratogens may include medications, diseases, infections, environmental pollutants, psychoactive drugs, and even poor nutrition.

References

Berry, R. J., & Zhu, L. (2002). Folic acid alone prevents neural tube defects: Evidence from the China study. Epidemiology, 13, 114–116.

Cohen, L., Friedman, J., Jefferson, J., Johnson, E., & Weiner, M. (1994). A reevaluation of risk of in utero exposure to lithium. JAMA 27(12), 146–150.

Friedman, J., & Polifka, J. (1994). Teratogenic effects of drugs: A resource for clinicians (TERIS). Baltimore, MD: The Johns Hopkins University Press.

Lightfoot, C., Cole, M. & Cole, S. R. (2009). The Development of Children (6th ed.). New York: Worth Publishers.

Moore, K., L., & Persaud, T. V. N. (1998). The developing human: Clinically oriented embryology. Philadelphia: Saunders.

Mountain States Genetics. (1995). Teratogen update. Genetic Drift, 12. Retrieved August 29, 2005, from http://www.mostgene.org/gd/gdvol12h.htm

Nelson, C., & Demmler, G. (1997). Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clinics in Perinatology, 24, 151–160.

Organization of Teratology Information Services (OTIS). (2005). Fact sheets. Retrieved August 29, 2005 from http://otispregnancy.org/otis_fact_sheets.asp

Physical and Theoretical Chemistry Lab. (2005). List of known and suspected teratogens. Retrieved August 30, 2005, from http://ptcl.chem.ox.ac.uk/MSDS/teratogens.html

The Teratology Society. Metabolic teratogens. Retrieved August 29, 2005, from http://teratology.org/jfs/teratologyindex.html

The Teratology Society. Pharmaceutical teratogens. Retrieved August 29, 2005, from http://teratology.org/jfs/teratologyindex.html

The Teratology Society. Recreational teratogens. Retrieved August 29, 2005, from http://teratology.org/jfs/teratologyindex.html

Trasler, J., & Doerksen, T. (1999). Teratogen update: Paternal exposures-Reproductive risks. Teratology, 60, 161–172.